{"id":885,"date":"2026-09-30T09:52:27","date_gmt":"2026-09-30T04:22:27","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-30\/"},"modified":"2026-10-05T20:43:05","modified_gmt":"2026-10-05T15:13:05","slug":"drreddy-share-price-today-2026-09-30","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-30\/","title":{"rendered":"Why Dr. Reddy&#8217;s Shares Fell 1.51% Today Amid Pharma Sector Weakness | 30 September 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: DRREDDY<\/strong> \u00b7 30 September 2026 \u00b7 Dated market coverage<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b91,233.00<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-1.51%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b91,244.60 \/ \u20b91,215.20<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b91,251.90<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>3,926,974<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>30 Sep 2026 \u2022 03:15 PM IST<\/div>\n<\/div>\n<\/div>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\" class=\"wt-card\">\n<div style=\"font-weight:900;color:#1f4d70;margin-bottom:7px;\" class=\"wt-card-title\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;\">\n<li>The stock is -1.51% at \u20b91,233.00.<\/li>\n<li><strong>Likely reason:<\/strong>Sectoral pressure and profit-taking after recent gains <\/li>\n<li>Approximate traded value is<strong>\u20b9484.20 crore<\/strong>. <\/li>\n<li>It is -12.86% from its 52-week high and +11.99% from its 52-week low.<\/li>\n<li>The stock is being compared with<strong>Nifty Pharma<\/strong>alongside the Nifty 50. <\/li>\n<\/ul><\/div>\n<h2>Why Is Dr. Reddy S Laboratories Share Price Falling 1.51% Today?<\/h2>\n<p class=\"wt-copy\">Latest NSE EOD report: 2026-09-29. Today&#8217;s Volume: 3,926,974; 5-Day Avg. Volume: 3,088,680; 20-Day Avg. Volume: 1,814,132; Volume vs 20-Day Avg.: 2.16x; Delivery Quantity: 2,450,987; Delivery %: 45.84%; Number of Trades: 116,376.<\/p>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Dr. Reddy&#8217;s Laboratories shares declined 1.51% to trade at \u20b91,233.0, moving closer to the lower end of the day&#8217;s range between \u20b91,215.2 and \u20b91,244.6. Trading activity picked up notably, with volumes running at 2.16 times the 20-day average, signaling heightened participation as the stock pulled back.<\/p>\n<p class=\"wt-copy\">The broader market and healthcare sector faced downward pressure during the session, with the Nifty falling 0.42% and the Nifty Pharma index dropping 1.84%. Dr. Reddy&#8217;s retracement aligns with the broader sectoral weakness, though the stock has managed a modest 1.80% gain over the past five trading sessions.<\/p>\n<p class=\"wt-copy\">Company developments provide backdrop context without serving as direct catalysts for today&#8217;s price action. Notably, the exchange recently sought clarification regarding a media report concerning a voluntary license for Gilead&#8217;s HIV prevention drug, while the company also entered into an exclusive distribution agreement with Takeda Biopharmaceuticals India for Qdenga\u00ae in the private Indian market.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\" class=\"wt-card\">\n<div style=\"gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\" class=\"wt-card-title\">\n<div style=\"font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p> <span style=\"background:#fff1cf;color:#8a6116;padding:3px 8px;border-radius:999px;font-weight:900;text-transform:uppercase;\">medium confidence<\/span> <\/div>\n<div style=\"font-weight:850;color:#20384a;margin-bottom:7px;\">Sectoral pressure and profit-taking after recent gains<\/div>\n<div style=\"\">The stock&#8217;s decline mirrors broader weakness in the pharmaceutical sector and profit-taking following a multi-session rebound, accompanied by elevated trading volumes.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Nifty Pharma sector fell 1.84%<\/li>\n<li>Volume was 2.16 times the 20-day average<\/li>\n<li>Prior two-session return stood at positive 4.24%<\/li>\n<\/ul><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid\" style=\"gap:16px;margin:14px 0 22px;width:100%;box-sizing:border-box;\">\n<div class=\"wt-card\" data-card=\"insider\" style=\"background:#edf5ff;border:1px solid #c9dbef;border-left:4px solid #4b7fb8;border-radius:10px\">\n<div class=\"wt-card-title\">Historical Insider Activity<\/div>\n<div class=\"wt-card-body\">\n<div class=\"wt-insider-row\">\n<div class=\"wt-insider-person\"><strong>Patrick Aghanian<\/strong><span class=\"wt-note\">Insider \/ disclosed person<\/span><\/div>\n<div><span class=\"wt-label\">Transaction<\/span><strong>Buy<\/strong><\/div>\n<div><span class=\"wt-label\">Quantity<\/span><strong>3,675 shares<\/strong><\/div>\n<div><span class=\"wt-label\">Trade date<\/span><strong>26 March 2026<\/strong><\/div>\n<\/div>\n<div class=\"wt-insider-row\">\n<div class=\"wt-insider-person\"><strong>Tricia Wetzel<\/strong><span class=\"wt-note\">Insider \/ disclosed person<\/span><\/div>\n<div><span class=\"wt-label\">Transaction<\/span><strong>Buy<\/strong><\/div>\n<div><span class=\"wt-label\">Quantity<\/span><strong>4,275 shares<\/strong><\/div>\n<div><span class=\"wt-label\">Trade date<\/span><strong>9 December 2025<\/strong><\/div>\n<\/div>\n<div class=\"wt-note\">Source: NSE transaction disclosures.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p class=\"wt-copy\"><strong>Price Position:<\/strong>The stock is around the middle of the day&#8217;s trading range. <\/p>\n<p class=\"wt-copy\"><strong>Move From Open:<\/strong>-0.56%. <\/p>\n<p class=\"wt-copy\"><strong>Intraday Range:<\/strong>2.35% of the previous close. <\/p>\n<p class=\"wt-copy\"><strong>5-Day Performance:<\/strong>+1.80%; <strong>20-Day Performance:<\/strong>+6.61%. <\/p>\n<\/p><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\" class=\"wt-card\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Exclusive Distribution Agreement for Qdenga<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">18-Sep-2026<\/div>\n<div style=\"\">Dr. Reddy&#8217;s Laboratories entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India Private Limited for the dengue vaccine Qdenga\u00ae in the private market in India. This partnership expands the company&#8217;s specialty vaccine portfolio within the domestic market.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>It strengthens Dr. Reddy&#8217;s domestic private market offerings in high-value preventive healthcare. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Exchange Clarification on HIV Prevention Drug Report<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">18-Sep-2026<\/div>\n<div style=\"\">The stock exchange sought clarification from Dr. Reddy&#8217;s Laboratories regarding a media report suggesting the company secured a voluntary license for Gilead&#8217;s once-yearly HIV prevention drug. The company provided its response to the exchange in compliance with disclosure norms.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Exchange clarifications help manage market disclosures and investor expectations regarding unconfirmed media reports. <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Upcoming financial results for the quarter ending September 30, 2026, scheduled for October 23, 2026<\/li>\n<li>Updates regarding the distribution rollout of Qdenga\u00ae in the Indian private market<\/li>\n<li>Delivery percentage trends relative to today&#8217;s elevated volume of 2.16x the 20-day average<\/li>\n<\/ul>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\" class=\"wt-copy\"><strong>Catalyst note:<\/strong>No single confirmed fundamental trigger drove today&#8217;s move, which appears driven by broader sectoral weakness and heightened volume activity. <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p class=\"wt-copy\">The stock&#8217;s decline mirrors broader weakness in the pharmaceutical sector and profit-taking following a multi-session rebound, accompanied by elevated trading volumes.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p class=\"wt-copy\">Today&#8217;s volume is 3,926,974. The latest 20-day average available is 1,814,132, equivalent to about 2.16x of the recent average.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p class=\"wt-copy\">Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the<a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>. <\/p>\n<div class=\"witty-related\"><\/div>\n<p><strong>Article by:<\/strong><a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><\/p>\n<div class=\"witty-disclaimer\"><strong>Disclaimer:<\/strong>Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors. This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security. Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions. <\/div>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-10-05\/\">Dr. Reddy&#8217;s Shares Dip 0.27% Amid Pharma Sector Consolidation \u2014 5 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-10-01\/\">Why Dr. Reddy&#8217;s Shares Fell 2.75% Today \u2014 1 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-29\/\">Dr. Reddy&#8217;s Lab Shares Rise: Why DRREDDY Stock is Moving Today \u2014 29 September 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/drreddy\/\">More Dr. Reddy S Laboratories news and dated analysis \u2192<\/a><\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-30\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-30\/\"}, \"headline\": \"Why Dr. Reddy's Shares Fell 1.51% Today Amid Pharma Sector Weakness | 30 September 2026\", \"description\": \"Dr. Reddy's Laboratories shares dropped 1.51% to \u20b91,233 amid broader pharmaceutical sector weakness and higher-than-average volume. Explore key drivers and trends.\", \"datePublished\": \"2026-09-30T04:22:27Z\", \"dateModified\": \"2026-10-05T14:43:53.354897+00:00\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/drreddy-company-news-2026-09-30.jpg\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Reddy&#8217;s Laboratories shares dropped 1.51% to \u20b91,233 amid broader pharmaceutical sector weakness and higher-than-average volume. Explore key drivers and trends.<\/p>\n","protected":false},"author":1,"featured_media":3175,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Why Dr. Reddy's Shares Fell 1.51% Today Amid Pharma Sector Weakness | 30 September 2026","_witty_meta_description":"Dr. Reddy's Laboratories shares dropped 1.51% to \u20b91,233 amid broader pharmaceutical sector weakness and higher-than-average volume. Explore key drivers and trends.","_witty_primary_phrase":"Dr. Reddy S Laboratories share price 2026-09-30","_witty_reason_label":"Sectoral pressure and profit-taking after recent gains","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[87],"class_list":["post-885","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-drreddy"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=885"}],"version-history":[{"count":5,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/885\/revisions"}],"predecessor-version":[{"id":3178,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/885\/revisions\/3178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/3175"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}